| Nicole Ann Johnson, RP | |
|
624 Patterson St, Cambridge, NE 69022-6597 | |
| (308) 697-3400 | |
| Not Available |
| Full Name | Nicole Ann Johnson |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 624 Patterson St, Cambridge, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982220232 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 11307 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nicole Ann Johnson, RP 624 Patterson St, Cambridge, NE 69022-6597 Ph: (308) 697-3400 | Nicole Ann Johnson, RP 624 Patterson St, Cambridge, NE 69022-6597 Ph: (308) 697-3400 |
News Archive
It's too early to draw conclusions about fraud in the Obamacare marketplaces, a congressional investigator said at a hearing focused on a report finding 11 out of 12 fake applicants were able to obtain subsidized health insurance. Republicans jumped on the report as proof that the health care law invites fraud, but the Government Accountability Office official said the sample is too small and investigators "can't draw any conclusions" until their work is complete.
Current PET-CT scanners with standard commercial software designed to provide images of the heart are falsely indicating coronary artery disease in as many as 40 percent of patients, according to a study published today on the cover page of the Journal of Nuclear Medicine.
According to ARRS' American Journal of Roentgenology (AJR), radiologists need to be cognizant of the association between coronavirus disease (COVID-19) mRNA vaccination and myocarditis, as well as the role of cardiac MRI for assessing suspected myocarditis postvaccination.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has expanded its compassionate use program for PV-10, making the agent, which is being developed as a therapeutic agent for a broad spectrum of cancers, available for select cancer patients in the United States. The program is already in progress in Australia, where it was initiated in June 2009.
One of the largest studies of its kind has found that people with coronary artery disease who have even a modest beer belly or muffin top are at higher risk for death than people whose fat collects elsewhere. The effect was observed even in patients with a normal Body Mass Index.
› Verified 5 days ago
Janet Mitchell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 624 Patterson St, Cambridge, NE 69022 Phone: 308-697-3400 Fax: 308-697-3401 | |
John William Kutnink, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 624 Patterson St, Cambridge, NE 69022 Phone: 308-697-3402 Fax: 308-697-3401 | |
Katherine Mccurdy, PHARMD, RP Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 624 Patterson St, Cambridge, NE 69022 Phone: 308-697-3400 | |
Mark Joseph Mccurdy, RP Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 624 Patterson St, Cambridge, NE 69022 Phone: 308-697-3400 Fax: 308-697-3401 |